BIO
ReciBioPharm is advancing xRNA manufacture by tackling the high cost and lengthy timelines through a continuous manufacturing platform that reduces production times from weeks to hours, dramatically lowers costs, and streamlines quality control. Through shortening time to first-in-human trials and increasing efficiency, this approach opens new opportunities for therapy developers and expands global patient access to life-saving treatments.